These results, together with a former report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 aid the notion of targeting ACKR3 as a unique method to modulate the opioid procedure, which could open new therapeutic avenues for opioid-connected Diseases. By ticking this box and submitting https://luisi849ckk1.bloggerchest.com/profile